|
⚲
|
| Keyboard |
| Moxham Christopher
✚
|
|
|---|---|
| CIK # | 0001843784 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001843784] | |
| 4 | [0001843784] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Fulcrum Therapeutics Inc | |
| Moxham Christopher |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fulcrum Therapeutics Inc FULC
Common Stock
|
2021-08-10 | Sell | 20,714 | $17.00 | 352,138 |
|
Fulcrum Therapeutics Inc FULC
Common Stockm
|
2021-08-10 | Sell | 31,071 | $18.00 | 559,278 |
|
Fulcrum Therapeutics Inc FULC
Common Stock
|
2021-08-10 | Option exercise | 31,071 | $7.84 | 243,597 |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2021-08-10 | Option exercise | 20,714 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Common Stock
|
2021-08-10 | Option exercise | 20,714 | $7.84 | 162,398 |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2021-08-10 | Option exercise | 31,071 | $0.00 | |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2021-02-08 | Grant | 100,000 | $0.00 |